Fisher & Paykel Healthcare Corporation Limited (FPH.AX)
AUD 33.88
(-1.83%)
AUD 33.88
(-1.83%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 320.4 Million NZD | -6.42% |
| 2023 | 342.38 Million NZD | 2.99% |
| 2022 | 332.43 Million NZD | 33.61% |
| 2021 | 248.82 Million NZD | 75.34% |
| 2020 | 141.9 Million NZD | 8.6% |
| 2019 | 130.66 Million NZD | 10.8% |
| 2018 | 117.93 Million NZD | -4.65% |
| 2017 | 123.69 Million NZD | 13.31% |
| 2016 | 109.16 Million NZD | 13.54% |
| 2015 | 96.14 Million NZD | 1.77% |
| 2014 | 94.47 Million NZD | 6.02% |
| 2013 | 89.11 Million NZD | 5.54% |
| 2012 | 84.43 Million NZD | 5.4% |
| 2011 | 80.1 Million NZD | 11.62% |
| 2010 | 71.76 Million NZD | 2.6% |
| 2009 | 69.94 Million NZD | 37.77% |
| 2008 | 50.77 Million NZD | 8.72% |
| 2007 | 46.69 Million NZD | 29.03% |
| 2006 | 36.19 Million NZD | 17.1% |
| 2005 | 30.9 Million NZD | 28.37% |
| 2004 | 24.07 Million NZD | 10.18% |
| 2003 | 21.85 Million NZD | 13.72% |
| 2002 | 19.21 Million NZD | 5.18% |
| 2001 | 18.27 Million NZD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 335.77 Million NZD | 0.0% |
| 2024 FY | 320.4 Million NZD | -6.42% |
| 2024 Q4 | 320.4 Million NZD | 0.0% |
| 2023 Q4 | 365.8 Million NZD | 0.0% |
| 2023 Q2 | 348.45 Million NZD | 0.0% |
| 2023 FY | 342.38 Million NZD | 2.99% |
| 2022 Q4 | 358.9 Million NZD | 0.0% |
| 2022 Q2 | 278.84 Million NZD | 0.0% |
| 2022 FY | 332.43 Million NZD | 33.61% |
| 2021 FY | 248.82 Million NZD | 75.34% |
| 2021 Q2 | 215.97 Million NZD | 0.0% |
| 2021 Q4 | 270.6 Million NZD | 0.0% |
| 2020 Q4 | 146.5 Million NZD | 0.0% |
| 2020 Q2 | 135.72 Million NZD | 0.0% |
| 2020 FY | 141.9 Million NZD | 8.6% |
| 2019 Q2 | 124.18 Million NZD | 0.0% |
| 2019 FY | 130.66 Million NZD | 10.8% |
| 2019 Q4 | 136.1 Million NZD | 0.0% |
| 2018 FY | 117.93 Million NZD | -4.65% |
| 2018 Q2 | 145.7 Million NZD | 0.0% |
| 2018 Q4 | 125.4 Million NZD | 0.0% |
| 2017 Q4 | 135 Million NZD | 0.0% |
| 2017 FY | 123.69 Million NZD | 13.31% |
| 2017 Q2 | 132.73 Million NZD | 0.0% |
| 2016 Q2 | 127.22 Million NZD | 0.0% |
| 2016 FY | 109.16 Million NZD | 13.54% |
| 2016 Q4 | 120.94 Million NZD | 0.0% |
| 2015 Q2 | 100.41 Million NZD | 0.0% |
| 2015 Q4 | 96.14 Million NZD | 0.0% |
| 2015 FY | 96.14 Million NZD | 1.77% |
| 2014 Q4 | 94.47 Million NZD | 8.59% |
| 2014 Q3 | 87 Million NZD | -13.26% |
| 2014 FY | 94.47 Million NZD | 6.02% |
| 2014 Q1 | 84.76 Million NZD | -4.87% |
| 2014 Q2 | 100.3 Million NZD | 18.33% |
| 2013 Q3 | 70.85 Million NZD | -5.96% |
| 2013 Q2 | 75.34 Million NZD | 1.83% |
| 2013 Q1 | 73.99 Million NZD | -12.36% |
| 2013 Q4 | 89.11 Million NZD | 25.76% |
| 2013 FY | 89.11 Million NZD | 5.54% |
| 2012 FY | 84.43 Million NZD | 5.4% |
| 2012 Q4 | 84.43 Million NZD | 0.0% |
| 2011 FY | 80.1 Million NZD | 11.62% |
| 2011 Q4 | 80.1 Million NZD | 0.0% |
| 2010 FY | 71.76 Million NZD | 2.6% |
| 2010 Q4 | 71.76 Million NZD | 0.0% |
| 2009 Q4 | 69.94 Million NZD | 0.0% |
| 2009 FY | 69.94 Million NZD | 37.77% |
| 2008 Q4 | 50.77 Million NZD | 0.0% |
| 2008 FY | 50.77 Million NZD | 8.72% |
| 2007 Q4 | 46.69 Million NZD | 0.0% |
| 2007 FY | 46.69 Million NZD | 29.03% |
| 2006 Q4 | 36.19 Million NZD | 0.0% |
| 2006 FY | 36.19 Million NZD | 17.1% |
| 2005 Q4 | 30.9 Million NZD | 0.0% |
| 2005 FY | 30.9 Million NZD | 28.37% |
| 2004 Q4 | 24.07 Million NZD | 0.0% |
| 2004 FY | 24.07 Million NZD | 10.18% |
| 2003 Q4 | 21.85 Million NZD | 0.0% |
| 2003 FY | 21.85 Million NZD | 13.72% |
| 2002 FY | 19.21 Million NZD | 5.18% |
| 2001 FY | 18.27 Million NZD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Austco Healthcare Limited | 10.66 Million AUD | -2903.093% |
| Nanosonics Limited | 20.23 Million AUD | -1483.16% |
| Osteopore Limited | 278.97 Thousand AUD | -114747.766% |
| SDI Limited | 28.74 Million AUD | -1014.512% |
| Trajan Group Holdings Limited | 27.92 Million AUD | -1047.277% |